Oaktree Specialty Lending...
15.36
0.09 (0.59%)
At close: Jan 15, 2025, 10:51 AM

Company Description

Oaktree Specialty Lending Corporation is a business development company specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity and management buyouts in small and mid-sized companies.

It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering, and media and advertising sectors.

It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies with enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million.

The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million.

It primarily invests in North America.

The fund seeks to be a lead investor in its portfolio companies.

Oaktree Specialty Lending Corporation
Oaktree Specialty Lending Corporation logo
Country United States
IPO Date Jun 12, 2008
Industry Financial - Credit Services
Sector Financial Services
Employees 0
CEO Armen Panossian J.D.

Contact Details

Address:
333 South Grand Avenue
Los Angeles, California
United States
Website https://www.oaktreespecialtylending.com

Stock Details

Ticker Symbol OCSL
Exchange NASDAQ
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001414932
CUSIP Number 67401P108
ISIN Number US67401P4054
Employer ID 26-1219283
SIC Code

Key Executives

Name Position
Armen Panossian J.D. Chief Executive Officer & Chief Investment Officer
Christopher McKown MD,Chief Financial Officer & Treasurer
Ashley Pak Chief Compliance Officer
Dr. Aman Kumar M.D. Managing Director & Co-Portfolio Manager of Life Sciences Direct Lending
Lucia S. Kim Senior Vice President
Mary Gallegly J.D. MD,General Counsel & Secretary
Mathew M. Pendo President
Michael Mosticchio Investor Relations
Raghav Khanna Managing Director & Co-Portfolio Manager
Sandeep Kumar Khorana Managing Director of Origination

Latest SEC Filings

Date Type Title
Jan 10, 2025 DEFA14A Filing
Jan 10, 2025 DEF 14A Filing
Dec 26, 2024 PRE 14A Filing
Nov 21, 2024 3 Filing
Nov 19, 2024 8-K Current Report
Nov 19, 2024 10-K Annual Report
Oct 28, 2024 40-17G Filing
Sep 23, 2024 4 Filing
Aug 14, 2024 4 Filing
Aug 02, 2024 424B5 Filing